洛阳证券公司联盟

中国CRO行业分析亚博88体育ios下载--任意三数字加yabo.com直达官网 Chinese CRO Industry Analysis Report

Capvision2019-04-22 23:46:33

尊敬的凯盛融英客户,

Dear Capvision?Clients,

近年来,中国CRO行业在政策、资本和技术的驱动下迎来了发展的新高峰,特别是在国内新药研发浪潮的推动下,药明生物于2017年赴港上市,药明康德、康龙化成、美迪西等也纷纷集中申报上市,CRO进入并购整合新常态,行业景气度持续上升。值得一提的是,药明康德于2018年4月24日进行申购,成为首只A股上市的独角兽。中国CRO行业发展的现状如何?市场驱动因素有哪些?行业竞争格局以及细分板块还存在哪些优质的投资标的?这些问题引起了投资者的广泛关注。


The Chinese CRO industry has recently reached a new peak of development, driven by new policies, capital, and technologies. Under the impetus of new drug research and development in China, WuXi Biologics went public in Hong Kong in 2017, with WuXi Apptec, Pharmaron, and Medicilon following it shortly thereafter. Mergers and acquisitions have become the new normal in the CRO industry, as it continues to thrive. WuXi Apptec will start taking subscriptions on April 24th, 2018, and will soon become the first A-share listed company in the industry. What is the Chinese CRO industry’s current stage of development? What are the driving factors in the market? What are the most promising investment targets in the overall competitive landscape and individual industry segments? These questions have attracted widespread attention from investors.?

凯盛于2018年4月24日出版本期亚博88体育ios下载--任意三数字加yabo.com直达官网。本研究通过专家访谈和调研,并结合公开信息对国内CRO行业的发展现状进行了系统的梳理,全面剖析CRO产业链上下游之间的关联性,并从项目需求和行业驱动因素方面解析国内CRO行业的市场规模及未来的增长潜力。此外,本研究从公司业务线、定价机制、人才架构、下游客户等多个维度对3家临床前CRO标杆企业和临床CRO行业的竞争格局进行了深入的分析。除目录外,正文内容共计30页左右Word,本亚博88体育ios下载--任意三数字加yabo.com直达官网适合于需要全面了解中国CRO市场概况以及对重点企业投资感兴趣的PE、VC机构。


The Capvision Research Team will publish the Chinese CRO Industry Analysis Report on April 24th, 2018. Through conducting expert interviews and industry research, combined with the systematic review of the development status of the domestic CRO industry, this report comprehensively analyzes the upstream and downstream industry segments in the CRO industry chain, as well as the market size and future development potential from the perspective of project requirements and factors driving the industry. Additionally, this report contains an in-depth analysis of the competitive landscape being navigated by three pre-clinical CRO benchmarking enterprises, and the clinical CRO industry from the aspects of business lines, pricing mechanisms, talent structures, and downstream customers. This report totals nearly 30 pages (excluding the contents section), and will be most beneficial to clients looking to gain a comprehensive understanding of the Chinese CRO industry, and those interested in investing in key enterprises.?


亚博88体育ios下载--任意三数字加yabo.com直达官网目录?

Contents?


1.?中国CRO产业链概况

Overview of the Chinese CRO Industry Chain

? ? ? ??1.1??CRO业务概览

? ?CRO Business

? ? ? ??1.2??CRO行业的发展状况

? ?Development of the CRO Industry

? ? ? ? 1.3??CRO企业与产业链上下游之间的关联性

? ?Correlation between the Upstream and Downstream of the Industry Chain and Individual Companies

2.?市场需求分析

Market Demand Analysis

? ? ? ? 2.1 ?行业规模

? ?Industry Scale

? ? ? ? 2.2 ?市场驱动因素

? ?Driving Factors in the Market

? ? ? ? ? ? ? ? ? 2.2.1 ?政策因素驱动

? ? ? ?Driving Policy Factors

? ? ? ? ? ? ? ? ? 2.2.2 ?CRO企业内生因素驱动

? ? ? ?Internal Driving Factors of CRO Businesses

? ? ? ? ? ? ? ? ? 2.2.3 ?药企外力因素驱动

? ? ? ?External Driving Factors of Pharmaceutical Companies

? ? ? ? 2.3 ?中国项目需求

? ?Project Requirements in China

? ? ? ? ? ? ? ? ? 2.3.1 ?仿制药一致性评价驱动临床试验需求

? ? ? ?Generic Drug Consistency Assessments Drive Clinical Trial Requirements

? ? ? ? ? ? ? ? ? 2.3.2 ?优先审评审批驱动新药申报需求

? ? ? ?Priority Review and Approval Drives New Drug Declaration Requirements

? ? ? ? 2.4 ?境外项目需求

? ?Overseas Project Requirements??

3.?中国CRO行业格局

Chinese CRO industry Structure

? ? ? ? 3.1 ?行业竞争格局与市场化程度

? ?Competitive Landscape and Extent of Marketization

? ? ? ? 3.2??市场占有率

? ?Market Share

4.?临床前CRO标杆企业分析

Analysis of Pre-clinical CRO Benchmarking Enterprises

? ? ? ? 4.1 ?标杆企业实力对比

? ?Comparison of Benchmarking Enterprises

? ? ? ? 4.2??药明康德(SH:603259)

? ? ? ? WuXi AppTecSH:603259

? ? ? ? ? ? ? ? ? 4.2.1??公司发展史和业务拆分

? ? ? ? ? ? ? ? ? Company History and Business Divisions

? ? ? ? ? ? ? ? ? 4.2.2??业务线及定价机制

? ? ? ? ? ? ? ? ? Business Lines and Pricing Mechanism

? ? ? ? ? ? ? ? ? 4.2.3??人才架构

? ? ? ?Staff Structure

? ? ? ? ? ? ? ? ? 4.2.4 ?下游客户分析

? ? ? ?Downstream Customer Analysis

? ?4.3??康龙化成(SZ:A17160)

? ? ? ? Pharmaron(SZ:A17160)

? ? ? ? ? ? ? ? ? 4.3.1??业务线及定价

? ? ? ?Business Lines and Pricing Mechanism

? ? ? ? ? ? ? ? ? 4.3.2??学历结构

? ? ? ?Educational Background

? ? ? ? ? ? ? ? ? 4.3.3??下游客户

? ? ? ?Downstream Customers

? ? ? ? 4.4 ?昭衍新药(SH:603127)

? ? ? ? JOINN(SH:603127)

? ? ? ? ? ? ? ? ? 4.4.1??业务线及定价

? ? ? ?Business Lines and Pricing Mechanism

? ? ? ? ? ? ? ? ? 4.4.2 ?人员架构及薪资水平

? ? ? ?Staff Structure and Salary Level

? ? ? ? ? ? ? ? ? 4.4.3??下游客户

? ? ? ?Downstream Customers

5.?临床 CRO 竞争格局

The Clinical CRO Competitive Landscape

? ? ? ? 5.1??市场占有率

? ?Market Share

? ? ? ? 5.2 ?人才与薪资水平

? ?Staff Structure and Salary Level

? ? ? ? 5.3??业务与客户结构

? ?Business and Customer Structure

6.?总结与展望

Summary and Prospects


凯盛融英医药生物市场热点月报目录

List of Monthly Hot Topics in the Bio-Pharmaceutical Market


1.?医药生物市场热点概览

Overview of Hot Topics in the Bio-Pharmaceutical Market

2.?一级市场热点追踪及分析

Tracking and Analysis of Hot Topics in the Primary Market

3.?二级市场热点追踪及分析

Tracking and Analysis of Hot Topics in the Secondary Market

4.?其他企业咨询热点追踪及分析

Tracking and Analysis of Other Enterprises' Consulting Focuses

5.?医药生物相关热点研究亚博88体育ios下载--任意三数字加yabo.com直达官网推荐

Recommendations of the Research Report on the Bio-Pharmaceutical Market




订阅亚博88体育ios下载--任意三数字加yabo.com直达官网 Subscribe?

《中国CRO行业分析亚博88体育ios下载--任意三数字加yabo.com直达官网》收费3小时,并赠送医疗行业2018年3月的市场热点亚博88体育ios下载--任意三数字加yabo.com直达官网。

?

此外,如需打包订购《中国CRO行业分析亚博88体育ios下载--任意三数字加yabo.com直达官网》+《中国生物药CDMO行业研究亚博88体育ios下载--任意三数字加yabo.com直达官网》(2017年7月出版,共40页word,涵盖药明生物[2269.HK]、百济神州[NASDAQ: BGNE]、迈百瑞和信达生物共计4家标杆企业分析)仅加收2小时。如需亚博88体育ios下载--任意三数字加yabo.com直达官网全文,欢迎与凯盛客户经理联系或发邮件至jsheng@capvision.com或anju@capvision.com


We will charge a fee of 3 hours for the Chinese CRO Industry Analysis Report, and include “List of Monthly Hot Topics in the Bio-Pharmaceutical Market in March 2018” for free.

?

In addition, if you make a package order of the Chinese CRO Industry Analysis Report, the China Bio-Pharma CDMO Industry Research Report (published in July 2017, totaling 40 pages, and analyzing 4 benchmarking enterprises: WuXi Biologics (2269.HK), BeigGene [NASDAQ: BGNE], MabPlex and Innovent), and the monthly report for March, you will be charged an extra 2 hours.

If you are interested in subscribing to this report, please feel free to contact your account manager or email?jsheng@capvision.comor anju@capvision.com.




凯盛市场研究亚博88体育ios下载--任意三数字加yabo.com直达官网是凯盛融英针对热门话题、热门产业与市场进行研究调查的亚博88体育ios下载--任意三数字加yabo.com直达官网,专注于分析行业最新动态、产业链主要环节中主要厂商的市场竞争格局、运营状况,帮助投资者判断相关企业的实际价值。凯盛市场研究亚博88体育ios下载--任意三数字加yabo.com直达官网通过问卷和专家访谈的形式收集行业发展趋势、主要厂家的销售额、利润率、库存等数据,并向读者展现相关公司的业绩表现和市场动态。如有定制化研究需求,欢迎与您的客户经理联系或发送邮件至anju@capvison.com


?Capvision’s industry reports focus on hot topics, industries, and markets, and are committed to helping investors make educated decisions by offering analysis of industrial dynamics, competitive patterns, and the operations of major players in the industrial chain. Information like turnover, profit rate, inventory data, etc., is acquired through survey responses and consultations with our experts.Therefore, this report will provide a means to easily find performances of related companies and general market status. If you have any specific questions, please feel free to contact your account manager or email:?anju@capvision.com.